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Abstract: While an adequate protein intake is important for the maintenance of muscle mass during
ageing, the amount and source of protein necessary for optimal prevention of sarcopenia remains to
be determined. The present study aimed to investigate the influence of the amount and source of
dietary proteins on sarcopenia risk in a cohort of 65–79-year-old European adults within the frame
of the NU-AGE study. A total of 986 participants were included in the analysis. Skeletal muscle
index (SMI), assessed by dual-energy X-ray absorptiometry (DXA), and handgrip strength (HG) were
employed to create a continuous sex-specific sarcopenia risk score (SRS). Total amount together with
animal- and plant-derived sources of proteins were obtained from a 7-day food record. Differences in
SRS were analysed across groups of total protein intake (<0.8 g/body weight (BW); 0.8–<1.0 g/BW;
1.0–<1.2 g/BW; and ≥1.2 g/BW). The association between SRS and the different sources of protein was
assessed using isocaloric substitution models adjusted by demographic, medical, and lifestyle factors.
A significant linear dose-response relationship was observed, with a lower SRS linked to higher
protein intakes. Based on the isocaloric substitution modelling, a reduced SRS was observed when
increasing plant protein to the detriment of animal protein, while holding total protein intake constant.
Further, this result remained significant after stratifying the analysis by adherence to different levels
of protein intake. Our findings suggest that older adults may benefit from increasing protein intakes
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above current recommendations. Besides total amount, protein source should be considered when
promoting health dietary habits in older adults for the prevention of sarcopenia.
Keywords: elderly; plant protein; animal protein; muscle mass; macronutrients; isocaloric substitution;
muscle strength; physical activity; metabolic syndrome
1. Introduction
The decline in muscle mass, strength, and related functional abilities accompanying the ageing
process have received considerable attention due to its association with an array of negative
health-related outcomes, such as falls, disability, loss of independence, and mortality [1]. In this
respect, sarcopenia is defined as a progressive skeletal muscle disorder operationalised by low levels
of muscle strength and muscle quantity, and with physical performance as an indicator of severity [2].
The progression of sarcopenia appears to be related to a complex interweaving of biological and
environmental determinants as people age. Among others, lifestyle behaviours including physical
activity and healthy dietary habits are considered key factors in counteracting age-related increases in
sarcopenia risk [3–5]. In particular, adequate protein intake is recognised as a core dietary element for
healthy ageing, where a large body of research highlights its links to muscle mass and function [6–15].
While the optimal amount of protein for maintenance of muscle health remains elusive,
dietary allowances between 0.8 and 1.2 g/BW have been recommended for older adults [15–23].
Importantly, the shape of the dose-response relationship between total protein intake and indices of
sarcopenia risk (i.e., muscle mass, strength) is yet to be determined and would increase our knowledge
whether a potential ceiling effect exists above which no further beneficial impacts on sarcopenia risk
are obtained.
Besides total protein intake, it has been shown that animal-based proteins induce a higher
stimulation of muscle protein synthesis [24,25], and higher physical function [10,26] compared to
plant-based proteins in older people. Paradoxically, evidence also suggest a positive link between
plant-based protein and muscle mass, strength, and functional performance [14,27–31]. Currently,
how different sources of protein may provide the best benefit in sarcopenia prevention remains unclear
and warrants further investigations in order to refine guidelines on healthy eating behaviours in
general, and protein sources in particular, for promoting muscle health during aging. For this purpose,
other factors of importance for preservation of muscle health, such as physical activity habits and
metabolic health status need to be considered when depicting the role of proteins, both in term of total
intake and food source.
Taken together, as both quantity and quality of protein intake may have separated potential
benefits on muscle health, it could be hypothesised that benefits linked to protein source may be
accentuated by a given level of total protein intake. Therefore, integrating both quantitative and
qualitative aspects when exploring links between proteins and muscle health would hold important
clinical implications related to sarcopenia prevention in aging populations.
Therefore, the present study aimed to investigate whether different food sources of dietary
proteins influence on sarcopenia risk across different levels of total protein intake in a cohort of older
European adults.
2. Materials and Methods
2.1. Participants
A total of 986 older men and women aged 65–79 years from four different countries (Italy, Poland,
The Netherlands, and The United Kingdom) were recruited within the frame of the NU-AGE project
(Clinicaltrials.gov, NCT01754012). A detailed description of the study design has been previously
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defined [32,33]. Written informed consent was obtained from each participant before starting and the
whole study conducted in accordance with the Declaration of Helsinki. Local ethical approval was
provided by independent committees in each recruiting centre.
2.2. Dietary Intake
Dietary intake was monitored by 1-week food record as previously described [32,34]. Briefly,
participants followed a training in advance and received written instructions about how to complete
a pre-formatted template which included 8 meal occasions during each day. Nutritional information
were obtained by software exploiting local food references [32,34,35] (INRAN and IEO in Italy, WISP in
the UK, NEVO 2011 in The Netherlands and NFNI in Poland). Total animal- and plant-based
protein intakes were normalised to body weight (g/BW). Based on established protein intake
recommendations [21,36], four groups were created according to the following intakes: <0.8 g/BW;
0.8–<1.0 g/BW; 1.0–<1.2 g/BW; and ≥1.2 g/BW.
2.3. Anthropometry and Body Composition
Height (cm) and body weight (kg) were obtained using a calibrated stadiometer and scale to the
nearest 0.1 cm and kg, respectively. A whole-body dual-energy X-ray absorptiometry (DXA) scan was
performed to determine total and regional body composition, including appendicular lean mass (kg).
All the scanners were daily calibrated against a standard calibration block and DXA performed by
trained technicians according to manufacturer instructions.
2.4. Sarcopenia Risk Score
SMI was calculated based on appendicular lean mass as described elsewhere [37–39]. Handgrip
strength was assessed with a Jamar handheld dynamometer (Patterson Medical, Warrenville, IL, USA)
and normalised by body weight. The continuous clustered sarcopenia risk score (SRS) consisted in a
sex-specific composite z-score, including skeletal muscle mass index (SMI) and handgrip strength, as
previously described [40]. These variables are representative of muscle quantity and strength according
to the most recent operational definition of sarcopenia by the European Work Group on Sarcopenia in
Older People [2].
2.5. Adherence to Physical Activity Guidelines
Time spent in moderate-to-vigorous physical activity (MVPA) was monitored during a 7-day
period using a waist-mounted Actigraph accelerometer (GT3x activity monitor, Actigraph, Pensacola,
FL, USA) as previously described [41]. Participants spending 150 or more minutes per week in MVPA,
based on the standardised cut-point of ≥2020 count per minutes [42], were classified as adhering to
guidelines about health-enhancing physical activity (PA) [43].
2.6. Assessment of Metabolic Risk
Participants were categorised as having high or low metabolic risk according to the International
Diabetes Federation (IDF) definition of metabolic syndrome (MetS) [44], as described elsewhere [45].
Standing waist circumference (WC), midway between the lowest rib and the iliac crest, was measured
to the nearest 0.1 cm. Automated electronic blood pressure monitors were employed to assess systolic
and diastolic blood pressures [39]. Blood glucose, high-density lipoprotein (HDL), and triglycerides
levels were measured using standard methodologies.
2.7. Statistical Analysis
Data are presented as arithmetic means and standard deviations, unless indicated. Differences
between groups of protein intake were determined by either one-way ANOVA with Sidak correction
or chi-squared test with Bonferroni correction. Prior to analysis of links between protein intake and
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SRS, no interactions with either PA or MetS were observed, therefore, final analyses were based
on the whole sample. Additionally, regression analysis was employed to assess the effect on SRS
by isocaloric substitution of animal-based protein with plant-based protein [40,46]. Estimates are
interpreted as changes in SRS with 0.1 g/BW increase of plant protein to the detriment of animal
protein, while keeping total protein intake constant. The regression model included total protein
intake, plant protein intake, and total energy intake and was adjusted. All models were adjusted for
age, recruiting centre, adherence to PA guidelines, prevalence of MetS, medication, smoking habits,
total energy intake, and fibre intake. All analyses were performed both on the whole population and
after stratification by groups of protein intake. Assumptions behind parametric analyses, including
normality, linearity, homogeneity of variance, and multicollinearity were checked. Small-to-moderate
effect sizes on SRS were detectable with a power of >80% given our sample size and alpha set to 0.05.
The analyses were conducted using SPSS version 27.
3. Results
A total of 417 men (aged 71.1 ± 4.1 years) and 569 women (aged 71.0 ± 3.9 years) were included in
the final analysis. SMI and handgrip were 30.1 ± 3.2% and 0.49 ± 0.09 kg/BW for men, and 24.4 ± 2.8%
and 0.37 ± 0.09 kg/BW for women, respectively. Basic characteristics presented across protein intake
groups are shown in Table 1. Gender distribution (58% female) was equal across groups of protein
intake. Notably, those belonging to the highest protein intake group (≥1.2 g/BW) had lower prevalence
of MetS and medication use, as well as higher adherence to PA guidelines compared to those with
protein intakes below 1.0 g/BW (Table 1).
Table 1. General characteristics of the study population by groups of protein intake.
Protein Intake a
<0.8 0.8–<1.0 1.0–<1.2 ≥1.2
n 205 296 279 206
Basic Characteristics
Age, y 71.7 ± 4.0 71.1 ± 4.1 70.9 ± 3.8 70.4 ± 3.9 *
Weight, kg 83.3 ± 13.8 75.6 ± 11.9 * 70.9 ± 11.7 * # 66.9 ± 11.1 * # +
Height, cm 166.7 ± 9.4 165.9 ± 8.8 164.5 ± 9.5 165 ± 9.2
Smoking, % never 46.1 45.9 55.6 58.3 *
Medication, % yes 85.3 82.2 70.6 * # 71.8 * #
PA. guidelines, % yes 44.1 51.0 55.2 67 * #
MetS, % yes 63.7 45.6 * 32.3 * # 27.2 * #
Continuous data are expressed as mean ± SD or are otherwise indicated. a g/BW. BW: Body weight; PA: Physical
activity; and MetS: Metabolic syndrome. * p < 0.05 vs. <0.8 g/BW protein intake; # p < 0.05 vs. 0.8–<1.0 g/BW protein
intake; and + p < 0.05 vs. 1.0–<1.2 g/BW protein intake.
Total energy intake and macronutrient distribution (E%) across protein intake groups are shown
in Table 2. Importantly, an average of 63% of the total protein intake was derived from animal sources,
with no significant differences between protein intake groups.
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Table 2. Macronutrient and energy intake of the study population by protein intake groups.
Protein Intake a
<0.8 0.8–<1.0 1.0–<1.2 ≥1.2
n 205 296 279 206
Total energy intake, Kcal 1510 ± 327 1718 ± 310 * 1878 ± 373 * # 2143 ± 440 * # +
Carbohydrates, E% 49.5 ± 7.1 49.3 ± 6.6 48.5 ± 6.2 47.9 ± 7.4
Fat, E% 31.1 ± 5.2 30.9 ± 5.4 31.2 ± 5.3 31.4 ± 6.0
Protein, E% 15.7 ± 2.6 16.3 ± 2.4 17.0 ± 2.6 * # 17.5 ± 2.7 * #
Plant Protein, % total protein 37.4 ± 9.9 36.5 ± 8.8 36.7 ± 9.6 36.7 ± 9.6
Animal Protein, % total protein 62.6 ± 9.9 63.5 ± 8.8 63.3 ± 9.6 63.3 ± 9.6
Continuous data are expressed as mean ± SD. a g/BW. E%: Percentage of total energy. * p < 0.05 vs. <0.8 g/BW
protein intake; # p < 0.05 vs. 0.8–<1.0 g/BW protein intake; and + p < 0.05 vs. 1.0–<1.2 g/BW protein intake.
Factorial ANOVA indicated a significant main effect of protein intake on SRS (p < 0.05),
which remained after adjustment by covariates, including adherence to PA guidelines and prevalence
of MetS. Importantly, post hoc-analysis revealed a linear dose-response manner of the main effect,
where a shift in protein intake group was linked to a significantly lower SRS (p < 0.05) (Figure 1a).
In addition, we extended the analysis to include main effects of protein intake groups on single
components of SRS. The analysis revealed similar trends of the dose-response relationship between
groups of protein intake and SMI and handgrip strength (Figure 1b,c).
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Figure 1. Differences in sarcopenia risk score (a), skeletal muscle index (b), and handgrip strength (c)
across groups of protein intake. Data are estimated marginal means ± SEM adjusted for age, recruiting
centre, medication, smoking habits, prevalence of MetS, adherence to PA guidelines, fibre intake,
and total energy intake. * p < 0.05 vs. < 0.8 g/BW protein intake; # p < 0.05 vs. 0.8–<1.0 g/BW protein
intake; and + p < 0.05 vs. 1.0–<1.2 g/BW protein intake.
The present study further investigated the potential role of protein sources on SRS using an
isocaloric substitution model. Our analysis showed that replacing an equal amount of animal-derived
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proteins by plant-derived proteins was associated with a significantly reduced SRS (Table 3). Strikingly,
the beneficial association on SRS by favouring plant-derived proteins in detriment of animal-derived
proteins was evident across all protein intake groups (Table 3), thus indicating the role of protein source
as independent of protein quantity.
Table 3. Isocaloric substitution of animal-based protein with plant-based protein on sarcopenia risk.
Sarcopenia Risk Score
Model β-Coeff. 95% CI p-Value
Whole Population
Plant Protein −0.249 −0.303 to −0.196 <0.001
<0.8 g/BW
Plant Protein −0.323 −0.498 to −0.149 <0.001
≥0.8–<1.0 g/BW
Plant Protein −0.198 −0.318 to −0.078 0.001
≥1.0–<1.2 g/BW
Plant Protein −0.276 −0.364 to −0.189 <0.001
≥1.2 g/BW
Plant Protein −0.234 −0.335 to −0.133 <0.001
CI: Confidence interval. Substitution model contains total protein intake, plant protein intake, and total energy
intake. Models were additionally adjusted for age, recruiting centre, medication, smoking habits, prevalence of
MetS, adherence to PA. guidelines, and fibre intake. Estimates are interpreted as the association of the sarcopenia
risk score (SRS) with 0.1 g/BW increase of plant protein to the detriment of animal protein, while keeping total
protein intake constant.
4. Discussion
The present study addressed the question of whether protein source matters for sarcopenia risk in
older adults when considering total protein intake and health-enhancing PA levels. Here we show that
increasing the proportion of plant-derived to the detriment of animal-derived proteins is beneficially
linked to lower sarcopenia risk in a cross-cultural sample of older European adults. Importantly,
the favourable impact of plant-derived proteins was evident across a broad range of total protein
intakes and independent of adherence to PA guidelines.
Our study suggests a beneficial role of increasing the relative amount of plant-derived to the
detriment of animal-derived proteins in the prevention of sarcopenia. It has previously been shown
that plant-derived proteins may represent an inadequate source of the essential amino acids lysine
and leucine [47–49], with a reduced capability to stimulate muscle protein synthesis [50–55], thereby
promoting animal-derived proteins as the primary source for maintenance of muscle mass and
function in older adults. However, several studies examining effects of plant-derived proteins on
protein synthesis were based on isolated and generally low digestible plant sources, such as soya
and wheat [24,25,51,52,56]. Interestingly, it has been suggested that no deficits regarding essential
amino acids such as lysine would be expected to occur with relative intakes of plant-derived proteins
below 70% of total intake [57]. Therefore, given an average consumption of 37% plant-derived proteins
in our study population, which is in line with previous data [58,59], alteration of the protein source
distribution in favour of plant-derived proteins would be feasible with safe margins against any
deficiencies in composition of essential amino acids.
The notion that animal-derived proteins are of particular importance for muscle health has been
challenged by recent reports showing that greater intakes of plant-derived proteins are related to
faster walking speed [14,27], and higher scores on the short physical performance battery using copula
graphical models [29]. Further, plant-derived proteins have also been associated to reduced loss of
muscle over a 4-year period in older adults [28]. To date, the beneficial impacts of plant-derived
proteins on indices of muscle health are not fully explained. It has been suggested that alkaline
plant-based diets, rich in minerals such as potassium and magnesium, may favour maintenance of
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muscle mass and function in older adults [60]. Further research is warranted in order to unravel links
between plant-derived proteins and muscle health.
Interestingly, the role of protein source in prevention of age-related muscle wasting might be
partly influenced by the total protein intake. For example, previous reports indicated that an adequate
amount of protein intake would attenuate any benefits related to protein sources [30,55,61,62]. In this
respect, an important finding in this study was that beneficial links of plant-derived proteins with
SRS and its components were evident across groups of protein intakes ranging from below 0.8 g/BW
to above 1.2 g/BW. Thus, impacts of protein source on muscle health seem independent of protein
consumption over a broad range of intakes in this population of older European men and women.
Our data not only confirm previously established links between total protein intake and muscle
mass and function [6,8–11,15,63,64], it further highlights a linear dose-response pattern indicating no
apparent ceiling effect within protein intakes ranging from 0.8 to 1.2 g/BW. Indeed, it is suggested that
maximal stimulation of muscle protein synthesis requires a greater relative protein intake in older
compared to younger adults [65]. Moreover, our analysis encompassed several other factors with
potential to influence on sarcopenia risk, including physical activity habits. Taken together, our data
extend current guidelines on diets for healthy aging, advocating greater protein intakes (1.2 g/BW) to
older adults regardless of adherence to guidelines on health-enhancing physical activity.
A strength of the present study is the inclusion of older adults from four European countries,
which allows to capture the role of dietary proteins on sarcopenia risk in geographically and culturally
diverse European populations. Moreover, the analysis encompassed several potential confounding
factors, including demographic, biologic. and behavioural aspects. The use of food record for the
estimation of protein intakes, DXA-derived assessment of muscle mass, and objective assessment
of physical activity in a large cohort of older adults further strengthen the validity of our analyses.
However, this study is not without limitations. The cross-sectionally-based analysis of isocaloric
substitution of plant- and animal-derived proteins precludes conclusions about causality, and even
though several covariates were considered we cannot rule out presence of residual confounding.
Moreover, caution should be taken when extending the study findings to populations including older
adults with frailty and overt disease.
5. Conclusions
The present study highlights the importance of both, amount and source of proteins for sarcopenia
risk in older adults. The linear dose-response pattern between protein amount and sarcopenia
risk, supports the promotion of protein intakes even above 1.2 g/BW in aging populations. Further,
modifying distribution of protein source in favour of plant-derived proteins is beneficially linked
to sarcopenia risk across a broad range of total protein intakes. This emphasizes the dual roles of
protein quantity and quality in preservation of muscle mass and function in older adults, regardless of
adherence to guidelines on health-enhancing physical activity.
Author Contributions: Conceptualization, D.M.-R., A.N., F.K., A.S. and C.F.; methodology, D.M.-R., A.N., F.K., A.S.
and C.F.; validation, D.M.-R.; formal analysis, D.M.-R., A.N., A.S. and F.K.; investigation, D.M.-R., A.N., A.S., A.B.,
L.C.P.G.M.d.G., E.J.M.F., A.A.M.B., D.M., J.K., B.P., A.J., S.F.-T., G.B., M.C., C.F. and F.K.; writing—original draft
preparation, D.M.-R., A.N., A.S. and F.K.; writing—review and editing, D.M.-R., A.N., A.S., A.B., L.C.P.G.M.d.G.,
E.J.M.F., A.A.M.B., D.M., J.K., B.P., A.J., S.F.-T., G.B., M.C., C.F. and F.K.; supervision, A.N. and F.K.; project
administration, A.S.; funding acquisition, C.F. All authors have read and agreed to the published version of
the manuscript.
Funding: This research was supported by the European Union’s Seventh Framework Program under agreement
no. 266486 (NU-AGE: New dietary strategies addressing the specific needs of the elderly population for healthy
aging in Europe).
Acknowledgments: We would like to express our gratitude to all participants and staff involved in the NU-AGE
project. We thank the EU HORIZON 2020 Research and Innovation Programme (European Joint Programming
Initiative “A healthy diet for a healthy life” “JPI HDHL” and the ERA-NET co-fund HDHL-INTIMIC) for
supporting A.S., A.N. and F.K., and the Russian Ministry of Science and Education Agreement No.13.1902.21.0026”
for supporting C.F.
Nutrients 2020, 12, 3601 8 of 11
Conflicts of Interest: The authors declare no conflict of interests.
References
1. Dodds, R.M.; Roberts, H.C.; Cooper, C.; Sayer, A.A. The epidemiology of sarcopenia. J. Clin. Densitom. 2015,
18, 461–466. [CrossRef]
2. Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.;
Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019,
48, 16–31. [CrossRef]
3. Robinson, S.; Cooper, C.; Aihie Sayer, A. Nutrition and sarcopenia: A review of the evidence and implications
for preventive strategies. J. Aging Res. 2012, 2012, 1–6. [CrossRef]
4. Kirk, B.; Mooney, K.; Amirabdollahian, F.; Khaiyat, O. Exercise and dietary-protein as a countermeasure to
skeletal muscle weakness: Liverpool hope university—Sarcopenia aging trial (LHU-SAT). Front. Physiol.
2019, 10, 1–11. [CrossRef]
5. Ortolá, R.; García-Esquinas, E.; García-Varela, G.; Struijk, E.A.; Rodríguez-Artalejo, F.; López-García, E.
Influence of changes in diet quality on unhealthy aging: The Seniors-ENRICA cohort. Am. J. Med. 2019,
132, 1091–1102.e9. [CrossRef]
6. Isanejad, M.; Mursu, J.; Sirola, J.; Kröger, H.; Rikkonen, T.; Tuppurainen, M.; Erkkilä, A.T. Dietary protein
intake is associated with better physical function and muscle strength among elderly women. Br. J. Nutr.
2016, 115, 1281–1291. [CrossRef]
7. Coelho-Júnior, H.; Milano-Teixeira, L.; Rodrigues, B.; Bacurau, R.; Marzetti, E.; Uchida, M. Relative protein
intake and physical function in older adults: A systematic review and meta-analysis of observational studies.
Nutrients 2018, 10, 1330. [CrossRef]
8. Farsijani, S.; Morais, J.A.; Payette, H.; Gaudreau, P.; Shatenstein, B.; Gray-Donald, K.; Chevalier, S. Relation
between mealtime distribution of protein intake and lean mass loss in free-living older adults of the NuAge
study. Am. J. Clin. Nutr. 2016, 104, 694–703. [CrossRef]
9. Gregorio, L.; Brindisi, J.; Kleppinger, A.; Sullivan, R.; Mangano, K.M.; Bihuniak, J.D.; Kenny, A.M.;
Kerstetter, J.E.; Insogn, K.L. Adequate dietary protein is associated with better physical performance among
post-menopausal women 60–90 years. J. Nutr. Health Aging 2014, 18, 155–160. [CrossRef]
10. McLean, R.R.; Mangano, K.M.; Hannan, M.T.; Kiel, D.P.; Sahni, S. Dietary protein intake is protective against
loss of grip strength among older adults in the framingham offspring cohort. J. Gerontol. Ser. A Biol. Sci.
Med. Sci. 2016, 71, 356–361. [CrossRef]
11. Houston, D.K.; Nicklas, B.J.; Ding, J.; Harris, T.B.; Tylavsky, F.A.; Newman, A.B.; Lee, J.S.; Sahyoun, N.R.;
Visser, M.; Kritchevsky, S.B. Dietary protein intake is associated with lean mass change in older,
community-dwelling adults: The health, aging, and body composition (Health ABC) study. Am. J.
Clin. Nutr. 2008, 87, 150–155. [CrossRef]
12. Gaffney-Stomberg, E.; Insogna, K.L.; Rodriguez, N.R.; Kerstetter, J.E. Increasing dietary protein requirements
in elderly people for optimal muscle and bone health. J. Am. Geriatr. Soc. 2009, 57, 1073–1079. [CrossRef]
13. Takae, R.; Hatamoto, Y.; Yasukata, J.; Kose, Y.; Komiyama, T.; Ikenaga, M.; Yoshimura, E.; Yamada, Y.;
Ebine, N.; Higaki, Y.; et al. Physical activity and/or high protein intake maintains fat-free mass in older
people with mild disability; the fukuoka island city study: A cross-sectional study. Nutrients 2019, 11, 2595.
[CrossRef]
14. Coelho-Junior, H.J.; Calvani, R.; Gonçalves, I.O.; Rodrigues, B.; Picca, A.; Landi, F.; Bernabei, R.; Uchida, M.C.;
Marzetti, E. High relative consumption of vegetable protein is associated with faster walking speed in
well-functioning older adults. Aging Clin. Exp. Res. 2019, 31, 837–844. [CrossRef]
15. Nilsson, A.; Montiel Rojas, D.; Kadi, F. Impact of meeting different guidelines for protein intake on muscle
mass and physical function in physically active older women. Nutrients 2018, 10, 1156. [CrossRef]
16. Volpi, E.; Campbell, W.W.; Dwyer, J.T.; Johnson, M.A.; Jensen, G.L.; Morley, J.E.; Wolfe, R.R. Is the optimal
level of protein intake for older adults greater than the recommended dietary allowance? J. Gerontol. Ser. A
Biol. Sci. Med. Sci. 2013, 68, 677–681. [CrossRef]
17. Morley, J.E.; Argiles, J.M.; Evans, W.J.; Bhasin, S.; Cella, D.; Deutz, N.E.P.; Doehner, W.; Fearon, K.C.H.;
Ferrucci, L.; Hellerstein, M.K.; et al. Nutritional recommendations for the management of sarcopenia. J. Am.
Med. Dir. Assoc. 2010, 11, 391–396. [CrossRef]
Nutrients 2020, 12, 3601 9 of 11
18. Landi, F.; Calvani, R.; Tosato, M.; Martone, A.M.; Ortolani, E.; Savera, G.; D’Angelo, E.; Sisto, A.; Marzetti, E.
Protein intake and muscle health in old age: From biological plausibility to clinical evidence. Nutrients 2016,
8, 295. [CrossRef]
19. Paddon-Jones, D.; Short, K.R.; Campbell, W.W.; Volpi, E.; Wolfe, R.R. Role of dietary protein in the sarcopenia
of aging. Am. J. Clin. Nutr. 2008, 87, 1562S–1566S. [CrossRef]
20. Bauer, J.; Biolo, G.; Cederholm, T.; Cesari, M.; Cruz-Jentoft, A.J.; Morley, J.E.; Phillips, S.; Sieber, C.; Stehle, P.;
Teta, D.; et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position
paper from the PROT-AGE study group. J. Am. Med. Dir. Assoc. 2013, 14, 542–559. [CrossRef]
21. Deutz, N.E.P.; Bauer, J.M.; Barazzoni, R.; Biolo, G.; Boirie, Y.; Bosy-Westphal, A.; Cederholm, T.;
Cruz-Jentoft, A.; Krznariç, Z.; Nair, K.S.; et al. Protein intake and exercise for optimal muscle function with
aging: Recommendations from the ESPEN Expert Group. Clin. Nutr. 2014, 33, 929–936. [CrossRef]
22. Beasley, J.M.; Deierlein, A.L.; Morland, K.B.; Granieri, E.C.; Spark, A. Is meeting the recommended
dietary allowance (RDA) for protein related to body composition among older adults? Results from the
Cardiovascular Health of Seniors and Built Environment Study. J. Nutr. Health Aging 2016, 20, 790–796.
[CrossRef]
23. Rafii, M.; Chapman, K.; Elango, R.; Campbell, W.W.; Ball, R.O.; Pencharz, P.B.; Courtney-Martin, G. Dietary
Protein requirement of men >65 years old determined by the indicator amino acid oxidation technique is
higher than the current estimated average requirement. J. Nutr. 2015, 146, 681–687. [CrossRef]
24. Gorissen, S.H.M.; Witard, O.C. Characterising the muscle anabolic potential of dairy, meat and plant-based
protein sources in older adults. Proc. Nutr. Soc. 2018, 77, 20–31. [CrossRef]
25. Phillips, S.M. Nutrient-rich meat proteins in offsetting age-related muscle loss. Meat Sci. 2012, 92, 174–178.
[CrossRef]
26. Bradlee, M.L.; Mustafa, J.; Singer, M.R.; Moore, L.L. High-protein foods and physical activity protect against
age-related muscle loss and functional decline. J. Gerontol. Ser. A 2018, 73, 88–94. [CrossRef]
27. Gazzani, D.; Zamboni, F.; Spelta, F.; Ferrari, P.; Mattioli, V.; Cazzoletti, L.; Zanolin, E.; Tardivo, S.; Ferrari, M.
Vegetable but not animal protein intake is associated to a better physical performance: A study on a general
population sample of adults. Food Nutr. Res. 2019, 63, 1–7. [CrossRef]
28. Chan, R.; Leung, J.; Woo, J.; Kwok, T. Associations of dietary protein intake on subsequent decline in muscle
mass and physical functions over four years in ambulant older Chinese people. J. Nutr. Health Aging 2014,
18, 171–177. [CrossRef]
29. Behrouzi, P.; Grootswagers, P.; Keizer, P.L.C.; Smeets, E.T.H.C.; Feskens, E.J.M.; de Groot, L.C.P.G.M.;
van Eeuwijk, F.A. Dietary intakes of vegetable protein, folate, and vitamins B-6 and B-12 are partially
correlated with physical functioning of dutch older adults using copula graphical models. J. Nutr. 2020, 150,
634–643. [CrossRef]
30. Huang, R.-Y.; Yang, K.-C.; Chang, H.-H.; Lee, L.-T.; Lu, C.-W.; Huang, K.-C. The Association between
total protein and vegetable protein intake and low muscle mass among the community-dwelling elderly
population in northern Taiwan. Nutrients 2016, 8, 373. [CrossRef]
31. Sahni, S.; Mangano, K.M.; Hannan, M.T.; Kiel, D.P.; McLean, R.R. Higher protein intake is associated with
higher lean mass and quadriceps muscle strength in adult men and women. J. Nutr. 2015, 145, 1569–1575.
[CrossRef]
32. Berendsen, A.; Santoro, A.; Pini, E.; Cevenini, E.; Ostan, R.; Pietruszka, B.; Rolf, K.; Cano, N.; Caille, A.;
Lyon-Belgy, N.; et al. Reprint of: A parallel randomized trial on the effect of a healthful diet on inflammageing
and its consequences in European elderly people: Design of the NU-AGE dietary intervention study. Mech.
Ageing Dev. 2014, 136–137, 14–21. [CrossRef]
33. Santoro, A.; Pini, E.; Scurti, M.; Palmas, G.; Berendsen, A.; Brzozowska, A.; Pietruszka, B.; Szczecinska, A.;
Cano, N.; Meunier, N.; et al. Combating inflammaging through a Mediterranean whole diet approach:
The NU-AGE project’s conceptual framework and design. Mech. Ageing Dev. 2014, 136–137, 3–13. [CrossRef]
34. Ostan, R.; Guidarelli, G.; Giampieri, E.; Lanzarini, C.; Berendsen, A.A.M.; Januszko, O.; Jennings, A.; Lyon, N.;
Caumon, E.; Gillings, R.; et al. Cross-sectional analysis of the correlation between daily nutrient intake
assessed by 7-day food records and biomarkers of dietary intake among participants of the NU-AGE study.
Front. Physiol. 2018, 9, 1–12. [CrossRef]
Nutrients 2020, 12, 3601 10 of 11
35. Berendsen, A.; van de Rest, O.; Feskens, E.; Santoro, A.; Ostan, R.; Pietruszka, B.; Brzozowska, A.;
Stelmaszczyk-Kusz, A.; Jennings, A.; Gillings, R.; et al. Changes in dietary intake and adherence to the
NU-AGE diet following a one-year dietary intervention among European older adults—Results of the
NU-AGE Randomized Trial. Nutrients 2018, 10, 1905. [CrossRef]
36. Joint WHO/FAO/UNU Expert Consultation. Protein and Amino Acid Requirements in Human Nutrition; World
Health Organ Technical Report Series; WHO: Geneva, Switzerland, 2007; Volume 935, pp. 1–265.
37. Santoro, A.; Guidarelli, G.; Ostan, R.; Giampieri, E.; Fabbri, C.; Bertarelli, C.; Nicoletti, C.; Kadi, F.;
de Groot, L.C.P.G.M.; Feskens, E.; et al. Gender-specific association of body composition with inflammatory
and adipose-related markers in healthy elderly Europeans from the NU-AGE study. Eur. Radiol. 2019,
29, 4968–4979. [CrossRef]
38. Guglielmi, G.; Ponti, F.; Agostini, M.; Amadori, M.; Battista, G.; Bazzocchi, A. The role of DXA in sarcopenia.
Aging Clin. Exp. Res. 2016, 28, 1047–1060. [CrossRef]
39. Santoro, A.; Bazzocchi, A.; Guidarelli, G.; Ostan, R.; Giampieri, E.; Mercatelli, D.; Scurti, M.; Berendsen, A.;
Surala, O.; Jennings, A.; et al. A cross-sectional analysis of body composition among healthy elderly from
the European NU-AGE study: Sex and country specific features. Front. Physiol. 2018, 9, 1693. [CrossRef]
40. Montiel-Rojas, D.; Santoro, A.; Nilsson, A.; Franceschi, C.; Capri, M.; Bazzocchi, A.; Battista, G.; de
Groot, L.C.P.G.M.; Feskens, E.J.M.; Berendsen, A.A.M.; et al. Beneficial role of replacing dietary saturated
fatty acids with polyunsaturated fatty acids in the prevention of sarcopenia: Findings from the NU-AGE
Cohort. Nutrients 2020, 12, 3079. [CrossRef]
41. Nilsson, A.; Wåhlin-Larsson, B.; Kadi, F. Physical activity and not sedentary time per se influences on
clustered metabolic risk in elderly community-dwelling women. PLoS ONE 2017, 12, e0175496. [CrossRef]
42. Troiano, R.P.; Berrigan, D.; Dodd, K.W.; Mâsse, L.C.; Tilert, T.; McDowell, M. Physical activity in the United
States measured by accelerometer. Med. Sci. Sport. Exerc. 2008, 40, 181–188. [CrossRef] [PubMed]
43. U.S. Department of Health and Human Service. Physical Activity Guidelines Advisory Committee Scientific
Report 2018; U.S. Department of Health and Human Service: Washington, DC, USA, 2018.
44. Alberti, K.G.M.M.; Zimmet, P.; Shaw, J. Metabolic syndrome-a new world-wide definition. A Consensus
Statement from the International Diabetes Federation. Diabet. Med. 2006, 23, 469–480. [CrossRef] [PubMed]
45. Montiel-Rojas, D.; Nilsson, A.; Santoro, A.; Franceschi, C.; Bazzocchi, A.; Battista, G.; de Groot, L.C.P.G.M.;
Feskens, E.J.M.; Berendsen, A.; Pietruszka, B.; et al. Dietary fibre may mitigate sarcopenia risk: Findings
from the NU-AGE cohort of older European adults. Nutrients 2020, 12, 1075. [CrossRef] [PubMed]
46. Skilton, M.R.; Laville, M.; Cust, A.E.; Moulin, P.; Bonnet, F. The association between dietary macronutrient
intake and the prevalence of the metabolic syndrome. Br. J. Nutr. 2008, 100, 400–407. [CrossRef]
47. Young, V.R.; Pellett, P.L. Plant proteins in relation to human protein and amino acid nutrition. Am. J.
Clin. Nutr. 1994, 59, 1203S–1212S. [CrossRef]
48. Millward, D.J. The nutritional value of plant-based diets in relation to human amino acid and protein
requirements. Proc. Nutr. Soc. 1999, 58, 249–260. [CrossRef]
49. Santarpia, L.; Contaldo, F.; Pasanisi, F. Dietary protein content for an optimal diet: A clinical view. J. Cachexia
Sarcopenia Muscle 2017, 8, 345–348. [CrossRef]
50. Volek, J.S.; Volk, B.M.; Gómez, A.L.; Kunces, L.J.; Kupchak, B.R.; Freidenreich, D.J.; Aristizabal, J.C.; Saenz, C.;
Dunn-Lewis, C.; Ballard, K.D.; et al. Whey protein supplementation during resistance training augments
lean body mass. J. Am. Coll. Nutr. 2013, 32, 122–135. [CrossRef]
51. Yang, Y.; Churchward-Venne, T.A.; Burd, N.A.; Breen, L.; Tarnopolsky, M.A.; Phillips, S.M. Myofibrillar
protein synthesis following ingestion of soy protein isolate at rest and after resistance exercise in elderly men.
Nutr. Metab. (Lond.) 2012, 9, 57. [CrossRef] [PubMed]
52. Gorissen, S.H.M.; Horstman, A.M.H.; Franssen, R.; Crombag, J.J.R.; Langer, H.; Bierau, J.; Respondek, F.;
van Loon, L.J.C. Ingestion of wheat protein increases in vivo muscle protein synthesis rates in healthy older
men in a randomized trial. J. Nutr. 2016, 146, 1651–1659. [CrossRef]
53. Hartman, J.W.; Tang, J.E.; Wilkinson, S.B.; Tarnopolsky, M.A.; Lawrence, R.L.; Fullerton, A.V.; Phillips, S.M.
Consumption of fat-free fluid milk after resistance exercise promotes greater lean mass accretion than does
consumption of soy or carbohydrate in young, novice, male weightlifters. Am. J. Clin. Nutr. 2007, 86, 373–381.
[CrossRef] [PubMed]
54. Wilkinson, S.B.; Tarnopolsky, M.A.; MacDonald, M.J.; MacDonald, J.R.; Armstrong, D.; Phillips, S.M.
Consumption of fluid skim milk promotes greater muscle protein accretion after resistance exercise than
Nutrients 2020, 12, 3601 11 of 11
does consumption of an isonitrogenous and isoenergetic soy-protein beverage. Am. J. Clin. Nutr. 2007,
85, 1031–1040. [CrossRef] [PubMed]
55. Berrazaga, I.; Micard, V.; Gueugneau, M.; Walrand, S. The role of the anabolic properties of plant-versus
animal-based protein sources in supporting muscle mass maintenance: A critical review. Nutrients 2019,
11, 1825. [CrossRef] [PubMed]
56. Coelho-Junior, H.J.; Marzetti, E.; Picca, A.; Cesari, M.; Uchida, M.C.; Calvani, R. Protein intake and frailty:
A matter of quantity, quality, and timing. Nutrients 2020, 12, 2915. [CrossRef] [PubMed]
57. de Gavelle, E.; Huneau, J.F.; Bianchi, C.M.; Verger, E.O.; Mariotti, F. Protein adequacy is primarily a matter of
protein quantity, not quality: Modeling an increase in plant: Animal protein ratio in French adults. Nutrients
2017, 9, 1333. [CrossRef]
58. Camilleri, G.M.; Verger, E.O.; Huneau, J.-F.; Carpentier, F.; Dubuisson, C.; Mariotti, F. Plant and animal
protein intakes are differently associated with nutrient adequacy of the diet of french adults. J. Nutr. 2013,
143, 1466–1473. [CrossRef]
59. Halkjær, J.; Olsen, A.; Overvad, K.; Jakobsen, M.U.; Boeing, H.; Buijsse, B.; Palli, D.; Tognon, G.; Du, H.;
van der, A.D.L.; et al. Intake of total, animal and plant protein and subsequent changes in weight or waist
circumference in European men and women: The Diogenes project. Int. J. Obes. 2011, 35, 1104–1113.
[CrossRef]
60. Ganapathy, A.; Nieves, J.W. Nutrition and sarcopenia—What do we know? Nutrients 2020, 12, 1755.
[CrossRef]
61. Isanejad, M.; Mursu, J.; Sirola, J.; Kröger, H.; Rikkonen, T.; Tuppurainen, M.; Erkkilä, A.T. Association of
protein intake with the change of lean mass among elderly women: The Osteoporosis Risk Factor and
Prevention—Fracture Prevention Study (OSTPRE-FPS). J. Nutr. Sci. 2015, 4, e41. [CrossRef]
62. Haub, M.D.; Wells, A.M.; Tarnopolsky, M.A.; Campbell, W.W. Effect of protein source on
resistive-training-induced changes in body composition and muscle size in older men. Am. J. Clin. Nutr.
2002, 76, 511–517. [CrossRef]
63. Beasley, J.M.; Wertheim, B.C.; LaCroix, A.Z.; Prentice, R.L.; Neuhouser, M.L.; Tinker, L.F.; Kritchevsky, S.;
Shikany, J.M.; Eaton, C.; Chen, Z.; et al. Biomarker-calibrated protein intake and physical function in the
women’s health initiative. J. Am. Geriatr. Soc. 2013, 61, 1863–1871. [CrossRef] [PubMed]
64. Li, C.Y.; Fang, A.P.; Ma, W.J.; Wu, S.L.; Li, C.L.; Chen, Y.M.; Zhu, H.L. Amount rather than animal vs.
plant protein intake is associated with skeletal muscle mass in community-dwelling middle-aged and
older Chinese adults: Results from the Guangzhou nutrition and health study. J. Acad. Nutr. Diet. 2019,
119, 1501–1510. [CrossRef] [PubMed]
65. Moore, D.R.; Churchward-Venne, T.A.; Witard, O.; Breen, L.; Burd, N.A.; Tipton, K.D.; Phillips, S.M. Protein
ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older
versus younger men. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2015, 70, 57–62. [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional
affiliations.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
